Analysts See $0.23 EPS for Tallgrass Energy GP, LP (TEGP); Bioxcel Therapeutics (BTAI) Shorts Decreased By 0.45%

April 17, 2018 - By Richard Conner

Bioxcel Therapeutics Inc (NASDAQ:BTAI) had a decrease of 0.45% in short interest. BTAI’s SI was 822,100 shares in April as released by FINRA. Its down 0.45% from 825,800 shares previously. With 40,400 avg volume, 20 days are for Bioxcel Therapeutics Inc (NASDAQ:BTAI)’s short sellers to cover BTAI’s short positions. The stock increased 1.08% or $0.1 during the last trading session, reaching $9.36. About 1,855 shares traded. BioXcel Therapeutics, Inc. (NASDAQ:BTAI) has 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

Analysts expect Tallgrass Energy GP, LP (NYSE:TEGP) to report $0.23 EPS on May, 2.They anticipate $0.02 EPS change or 9.52% from last quarter’s $0.21 EPS. TEGP’s profit would be $42.51M giving it 23.64 P/E if the $0.23 EPS is correct. After having $0.13 EPS previously, Tallgrass Energy GP, LP’s analysts see 76.92% EPS growth. The stock increased 1.74% or $0.3716 during the last trading session, reaching $21.7516. About 142,061 shares traded. Tallgrass Energy GP, LP (NYSE:TEGP) has declined 34.57% since April 17, 2017 and is downtrending. It has underperformed by 46.12% the S&P500.

BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on novel artificial intelligence drug development in the fields of neuroscience and immuno-oncology in the United States. The company has market cap of $146.44 million. The firm is involved in developing BXCL501, a sublingual thin film formulation of dexmedetomidine designed for acute treatment of agitation resulting from neurological and psychiatric disorders; and BXCL701, an immuno-oncology agent designed for the treatment of prostate and pancreatic cancers. It currently has negative earnings. It is also developing BXCL502, a novel approach to the treatment of symptoms resulting from neurological disorders; and BXCL702, an immuno-oncology agent for hematological malignancies.

Tallgrass Energy GP, LP, through its interests in Tallgrass Equity, LLC, provides crude oil transportation services to clients in Wyoming, Colorado, and the surrounding regions of the United States. The company has market cap of $4.02 billion. It operates through three divisions: Crude Oil Transportation & Logistics, Natural Gas Transportation & Logistics, and Processing & Logistics. It currently has negative earnings. The firm also provides natural gas transportation and storage services for clients in the Rocky Mountain, Midwest, and Appalachian regions.

Among 11 analysts covering Tallgrass Energy GP (NYSE:TEGP), 5 have Buy rating, 2 Sell and 4 Hold. Therefore 45% are positive. Tallgrass Energy GP had 48 analyst reports since August 4, 2015 according to SRatingsIntel. The rating was maintained by Credit Suisse on Thursday, May 19 with “Outperform”. The stock of Tallgrass Energy GP, LP (NYSE:TEGP) has “Buy” rating given on Tuesday, March 27 by Stifel Nicolaus. As per Tuesday, March 27, the company rating was maintained by Citigroup. The rating was maintained by Stifel Nicolaus with “Buy” on Wednesday, February 14. The firm earned “Sell” rating on Thursday, December 15 by Goldman Sachs. Robert W. Baird maintained the shares of TEGP in report on Thursday, February 8 with “Buy” rating. The stock of Tallgrass Energy GP, LP (NYSE:TEGP) has “Neutral” rating given on Monday, February 8 by Robert W. Baird. As per Thursday, February 18, the company rating was maintained by RBC Capital Markets. The rating was maintained by Barclays Capital with “Overweight” on Friday, August 4. The firm has “Overweight” rating by Barclays Capital given on Thursday, February 18.

Tallgrass Energy GP, LP (NYSE:TEGP) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Richard Conner

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: